Sodium-glucose cotransporter-2 inhibitors improve FibroScan-aspartate aminotransferase scores in patients with nonalcoholic fatty liver disease complicated by type 2 diabetes

导出原文传递

翻译打印收藏纠错

作者： Yutaro,Ogawa ^[1] ; Takashi,Nakahara ; Yuwa,Ando ; Kenji,Yamaoka ; Yasutoshi,Fujii ; Shinsuke,Uchikawa ; Hatsue,Fujino ; Atsushi,Ono ; Eisuke,Murakami ; Tomokazu,Kawaoka ; Daiki,Miki ; Masami,Yamauchi ; Masataka,Tsuge ; Michio,Imamura ; Shiro,Oka

作者单位： Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima ^[1]

发布时间 2023-09-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

European journal of gastroenterology and hepatology

2023年35卷9期

989-996页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Sodium-glucose cotransporter-2 inhibitors improve FibroScan-aspartate aminotransferase scores in patients with nonalcoholic fatty liver disease complicated by type 2 diabetes

European journal of gastroenterology and hepatology

相似文献

European journal of gastroenterology and hepatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Sodium-glucose cotransporter-2 inhibitors improve FibroScan-aspartate aminotransferase scores in patients with nonalcoholic fatty liver disease complicated by type 2 diabetes

European journal of gastroenterology and hepatology

相似文献

European journal of gastroenterology and hepatology

相关期刊

检索历史清除